Voyageur Pharmaceuticals Ltd Cash Flow Conversion Efficiency

Latest as of November 2025: -0.295x

Voyageur Pharmaceuticals Ltd cash flow conversion efficiency. Based on the latest financial reports, Voyageur Pharmaceuticals Ltd (VM) has a cash flow conversion efficiency ratio of -0.295x as of November 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-369.98K ≈ $-267.64K USD) by net assets (CA$1.25 Million ≈ $906.00K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Voyageur Pharmaceuticals Ltd for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Voyageur Pharmaceuticals Ltd (2011–2025)

Cash flow conversion efficiency of Voyageur Pharmaceuticals Ltd from 2011 to 2025. This chart illustrates how Voyageur Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Voyageur Pharmaceuticals Ltd for real-time trading data and today's change.

Voyageur Pharmaceuticals Ltd Cash Flow Conversion Ratio Explained

Voyageur Pharmaceuticals Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Voyageur Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Voyageur Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Review VM cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Trinity Watthana Public Company Limited BK:TNITY	0.056x
Macompta Fr Sa PA:MLMCA	N/A
Black Iron Inc. TO:BKI	0.093x
PCCS Group Bhd KLSE:6068	0.196x
Lighting and Equipment Public Company Limited BK:L&E	0.013x
111 Inc NASDAQ:YI	-3.363x
Yorbeau Resources Inc TO:YRB	-0.014x
Cordoba Minerals Corp V:CDB	14.511x

Annual Cash Flow Conversion Efficiency for Voyageur Pharmaceuticals Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Voyageur Pharmaceuticals Ltd from 2011 to 2025. Also see VM asset base for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-11-30	CA$1.25 Million ≈ $906.00K	CA$-2.89 Million ≈ $-2.09 Million	-2.310x	-243.80%
2024-11-30	CA$449.96K ≈ $325.49K	CA$-302.29K ≈ $-218.67K	-0.672x	+2.69%
2023-11-30	CA$1.44 Million ≈ $1.04 Million	CA$-991.25K ≈ $-717.06K	-0.690x	+41.17%
2022-11-30	CA$1.46 Million ≈ $1.06 Million	CA$-1.72 Million ≈ $-1.24 Million	-1.174x	-35.22%
2021-11-30	CA$1.91 Million ≈ $1.38 Million	CA$-1.65 Million ≈ $-1.20 Million	-0.868x	+2.33%
2020-11-30	CA$306.33K ≈ $221.60K	CA$-272.19K ≈ $-196.90K	-0.889x	-5.05%
2019-11-30	CA$754.09K ≈ $545.50K	CA$-637.81K ≈ $-461.38K	-0.846x	+11.07%
2018-11-30	CA$515.68K ≈ $373.04K	CA$-490.45K ≈ $-354.79K	-0.951x	-113.60%
2017-11-30	CA$-89.24K ≈ $-64.55K	CA$-624.24K ≈ $-451.56K	6.995x	+13473.35%
2016-11-30	CA$670.46K ≈ $485.00K	CA$-35.07K ≈ $-25.37K	-0.052x	+94.07%
2015-11-30	CA$80.07K ≈ $57.92K	CA$-70.65K ≈ $-51.11K	-0.882x	-204.17%
2014-11-30	CA$81.56K ≈ $59.00K	CA$-23.66K ≈ $-17.11K	-0.290x	+6.71%
2013-11-30	CA$176.02K ≈ $127.33K	CA$-54.73K ≈ $-39.59K	-0.311x	-3070.28%
2012-11-30	CA$221.34K ≈ $160.12K	CA$2.32K ≈ $1.68K	0.010x	+106.87%
2011-11-30	CA$185.00K ≈ $133.83K	CA$-28.19K ≈ $-20.39K	-0.152x	--

About Voyageur Pharmaceuticals Ltd

V:VM Canada Drug Manufacturers - Specialty & Generic

Market Cap

$15.50 Million

CA$21.43 Million CAD

Market Cap Rank

#25784 Global

#1015 in Canada

Share Price

CA$0.12

Change (1 day)

+0.00%

52-Week Range

CA$0.08 - CA$0.20

All Time High

CA$0.34